Innate immune dysregulation in monocytes in sickle cell disease

Authors: Sarah Hinderstein, Gemma Vidal-Pedrola, Subhasis Mohanty, Irene Matos, Fanny Alarcon, Judith Carbonella, Cecelia Calhoun, Lakshmanan Krishnamurti, Albert Shaw, Inci Yildirim

Published: November 3, 2025

Previous
Previous

Role of Menstrual Bleeding Assessments in Sickle Cell Clinics

Next
Next

Revisiting acute chest syndrome (ACS) associated with sickle cell disease (SCD) vaso-occlusive pain episodes (VOE): Insight from a prospective, multicenter Phase-3 randomized controlled trial